RMD vs TMP · P/E 29, $37.68B cap vs P/E 7.5, rev $79.3M
ResMed Inc (RMD) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
RMD does not have a complete income-statement cache yet.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the RMD and TMP stock pages for the full models.
Not investment advice.